Page 133 - Read Online

Ibrahim et al ALDHs and prostate cancer

204. RNAs for aldehyde dehydrogenase 1, aldehyde dehydrogenase 2,
7. Karlou M, Tzelepi V, Efstathiou E. Therapeutic targeting of the and aldehyde dehydrogenase 5 in human tissues. J Investig Med
prostate cancer microenvironment. Nat Rev Urol 2010;7:494-509. 1996;44:42-6.
8. Zhu ML, Kyprianou N. Androgen receptor and growth factor 28. Yanagawa Y, Chen JC, Hsu LC, Yoshida A. The transcriptional
signaling cross-talk in prostate cancer cells. Endocr Relat Cancer regulation of human aldehyde dehydrogenase I gene. The
2008;15:841-9. structural and functional analysis of the promoter. J Biol Chem
9. Yauch RL, Gould SE, Scales SJ, Tang T, Tian H, Ahn CP, Marshall 1995;270:17521-7.
D, Fu L, Januario T, Kallop D, Nannini-Pepe M, Kotkow K, Marsters 29. Vasiliou V, Pappa A, Estey T. Role of human aldehyde dehydrogenases
JC, Rubin LL, de Sauvage FJ. A paracrine requirement for hedgehog in endobiotic and xenobiotic metabolism. Drug Metab Rev
signalling in cancer. Nature 2008;455:406-10. 2004;36:279-99.
10. Grose R, Dickson C. Fibroblast growth factor signaling in 30. Alnouti Y, Klaassen CD. Tissue distribution, ontogeny, and regulation
tumorigenesis. Cytokine Growth Factor Rev 2005;16:179-86. of aldehyde dehydrogenase (Aldh) enzymes mRNA by prototypical
11. Nam S, Kim DW, Cheng JQ, Zhang SM, Lee JH, Buettner R, microsomal enzyme inducers in mice. Toxicol Sci 2008;101:51-64.
Mirosevich J, Lee FY, Jove R. Action of the Src family kinase 31. Black WJ, Stagos D, Marchitti SA, Nebert DW, Tipton KF, Bairoch
inhibitor, dasatinib (BMS-354825), on human prostate cancer cells. A, Vasiliou V. Human aldehyde dehydrogenase genes: alternatively
Cancer Res 2005;65:9185-9. spliced transcriptional variants and their suggested nomenclature.
12. Bhowmick NA, Chytil A, Plieth D, Gorska AE, Dumont N, Shappell Pharmacogenet Genomics 2009;19:893-902.
S, Washington MK, Neilson EG, Moses HL. TGF-beta signaling in 32. Koppaka V, Thompson DC, Chen Y, Ellermann M, Nicolaou KC,
fibroblasts modulates the oncogenic potential of adjacent epithelia. Juvonen RO, Petersen D, Deitrich RA, Hurley TD, Vasiliou V.
Science 2004;303:848-51. Aldehyde dehydrogenase inhibitors: a comprehensive review of
13. Goel HL, Li J, Kogan S, Languino LR. Integrins in prostate cancer the pharmacology, mechanism of action, substrate specificity, and
progression. Endocr Relat Cancer 2008;15:657-64. clinical application. Pharmacol Rev 2012;64:520-39.
14. Shou JY, Ross S, Koeppen H, de Sauvage FJ, Gao WQ. Dynamics 33. Yokoyama A, Muramatsu T, Omori T, Yokoyama T, Matsushita
of notch expression during murine prostate development and S, Higuchi S, Maruyama K, Ishii H. Alcohol and aldehyde
tumorigenesis. Cancer Res 2001;61:7291-7. dehydrogenase gene polymorphisms and oropharyngolaryngeal,
15. van den Hoogen C, van der Horst G, Cheung H, Buijs JT, Lippitt JM, esophageal and stomach cancers in Japanese alcoholics.
Guzman-Ramirez N, Hamdy FC, Eaton CL, Thalmann GN, Cecchini Carcinogenesis 2001;22:433-9.
MG, Pelger RC, van der Pluijm G. High aldehyde dehydrogenase 34. Onenli-Mungan N, Yuksel B, Elkay M, Topaloglu AK, Baykal T,
activity identifies tumor-initiating and metastasis-initiating cells in Ozer G. Type II hyperprolinemia: a case report. Turk J Pediatr
human prostate cancer. Cancer Res 2010;70:5163-73. 2004;46:167-9.
16. Clarke MF, Dick JE, Dirks PB, Eaves CJ, Jamieson CH, Jones DL, 35. Akaboshi S, Hogema BM, Novelletto A, Malaspina P, Salomons
Visvader J, Weissman IL, Wahl GM. Cancer stem cells--perspectives GS, Maropoulos GD, Jakobs C, Grompe M, Gibson KM. Mutational
on current status and future directions: AACR Workshop on cancer spectrum of the succinate semialdehyde dehydrogenase (ALDH5A1)
stem cells. Cancer Res 2006;66:9339-44. gene and functional analysis of 27 novel disease-causing mutations
17. Zhang JW, Niu C, Ye L, Huang HY, He X, Tong WG, Ross J, Haug in patients with SSADH deficiency. Hum Mutat 2003;22:442-50.
J, Johnson T, Feng JQ, Harris S, Wiedemann LM, Mishina Y, Li LH. 36. Mills PB, Struys E, Jakobs C, Plecko B, Baxter P, Baumgartner
Identification of the haematopoietic stem cell niche and control of the M, Willemsen MA, Omran H, Tacke U, Uhlenberg B, Weschke B,
niche size. Nature 2003;425:836-41. Clayton PT. Mutations in antiquitin in individuals with pyridoxine-
18. Suda T, Arai F, Hirao A. Hematopoietic stem cells and their niche. dependent seizures. Nat Med 2006;12:307-9.
Trends Immunol 2005;26:426-33. 37. Baumgartner MR, Hu CA, Almashanu S, Steel G, Obie C, Aral B,
19. Borovski T, Melo FDE, Vermeulen L, Medema JP. Cancer stem cell Rabier D, Kamoun P, Saudubray JM, Valle D. Hyperammonemia
niche: the place to be. Cancer Res 2011;71:634-9. with reduced ornithine, citrulline, arginine and proline: a new inborn
20. Yi SY, Hao YB, Nan KJ, Fan TL. Cancer stem cells niche: a target error caused by a mutation in the gene encoding delta(1)-pyrroline-5-
for novel cancer therapeutics. Cancer Treat Rev 2013;39:290-6. carboxylate synthase. Hum Mol Genet 2000;9:2853-8.
21. Maitland NJ, Collins AT. Prostate cancer stem cells: a new target for 38. Enomoto N, Takase S, Takada N, Takada A. Alcoholic liver disease
therapy. J Clin Oncol 2008;26:2862-70. in heterozygotes of mutant and normal aldehyde dehydrogenase-2
22. Maitland NJ, Collins AT. Cancer stem cells - a therapeutic target? genes. Hepatology 1991;13:1071-5.
Curr Opin Mol Ther 2010;12:662-73. 39. Kamino K, Nagasaka K, Imagawa M, Yamamoto H, Yoneda H,
23. Kozma E, Jayasekara PS, Squarcialupi L, Paoletta S, Moro S, Ueki A, Kitamura S, Namekata K, Miki T, Ohta S. Deficiency in
Federico S, Spalluto G, Jacobson KA. Fluorescent ligands for mitochondrial aldehyde dehydrogenase increases the risk for late-
adenosine receptors. Bioorg Med Chem Lett 2013;23:26-36. onset Alzheimer’s disease in the Japanese population. Biochem
24. Marchitti SA, Brocker C, Stagos D, Vasiliou V. Non-P450 aldehyde Biophys Res Commun 2000;273:192-6.
oxidizing enzymes: the aldehyde dehydrogenase superfamily. Expert 40. Lohberger B, Rinner B, Stuendl N, Absenger M, Liegl-Atzwanger B,
Opin Drug Metab Toxicol 2008;4:697-720. Walzer SM, Windhager R, Leithner A. Aldehyde dehydrogenase 1, a
25. Vasiliou V, Nebert DW. Analysis and update of the human aldehyde potential marker for cancer stem cells in human sarcoma. PLoS One
dehydrogenase (ALDH) gene family. Hum Genomics 2005;2:138-43. 2012;7:e43664.
26. Sladek NE. Human aldehyde dehydrogenases: potential pathological, 41. Shimamura M, Nagayama Y, Matsuse M, Yamashita S, Mitsutake
pharmacological, and toxicological impact. J Biochem Mol Toxicol N. Analysis of multiple markers for cancer stem-like cells in human
2003;17:7-23. thyroid carcinoma cell lines. Endocr J 2014;61:481-90.
27. Stewart MJ, Malek K, Crabb DW. Distribution of messenger 42. Kunju LP, Cookingham C, Toy KA, Chen W, Sabel MS, Kleer CG.

Journal of Cancer Metastasis and Treatment ¦ Volume 4 ¦ Aug 21, 2018 11